Orthopaedics

US Demand For Orthopaedic Implants to Approach $ 22 Billion in 2012

The market for reconstructive joint replacements, which is forecast to reach $9 billion in 2012, will gain upward momentum

US demand for orthopaedic implants will increase 8.9 per cent annually to nearly $22 billion in 2012, with the four major product segments - reconstructive joint replacements, spinal implants, orthobiologics and trauma implants, all providing strong growth opportunities. The market for reconstructive joint replacements, which is forecast to reach $9 billion in 2012, will gain upward momentum from an aging population and the widespread prevalence of physically active lifestyles. These and other trends are presented in 'Orthopaedic Implants,' a new study from The Freedonia Group, a US-based industry research firm. Knees and hips, which are highly vulnerable to degeneration caused by arthritic conditions, will continue to account for the vast majority of reconstructive joint replacements, says the study. Continuing advances in materials and design will improve the safety and performance features of knee and hip implants and encourage their expanding use in the treatment of severe arthritis. Among other reconstructive joint replacements, shoulder systems will post the strongest demand. Spinal implants will show strong growth due to advances in product technologies and related surgical techniques, coupled with an increasing prevalence of chronic back conditions. Fixation devices and artificial discs used in spinal fusion and motion preservation surgeries, especially procedures for the repair of vertebrae and replacement of degenerative discs, will account for the largest share of the market and best growth opportunities. Orthobiologics will realise strong growth as breakthroughs in biotechnology and nanotechnology lead to the commercialisation of new and improved products. Growth factors, grafts and synthetic materials for the replacement and fortification of diseased and damaged bone are the prime factors responsible to make this segment fare well in the market place. Ongoing formulation improvements will keep bone cement a leading material used in the placement of reconstructive joint replacements and spinal implants.

EH News Bureau